← Back to Search

Behavioral Intervention

MBSR for Chronic Pain

N/A
Recruiting
Led By Todd Favorite, Ph.D.
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Any form of self-reported chronic pain (except cancer related pain)
A form of chronic pain disorder other than chronic lower back pain (cLBP) - examples include chronic pain associated with rheumatoid arthritis, fibromyalgia, neuropathy, neuralgia, etc.
Must not have
Unable to speak and write English
Visual or hearing difficulties that would preclude participation
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (pre-treatment), 8 and 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is looking at how well MBSR works for people with chronic pain. They think that some people might respond better to MBSR than others, and they want to find out why.

Who is the study for?
This trial is for adults over 18 with various chronic pain disorders, excluding lower back pain linked to specific conditions. Participants should have experienced pain for at least six months and on most days, with significant daily life interference due to pain. Those with cancer-related pain or sensory impairments that would hinder participation are not eligible.
What is being tested?
The study aims to understand how Mindfulness-based Stress Reduction (MBSR) helps manage chronic pain symptoms in different individuals. It will explore if light phenotyping can predict who benefits most from MBSR by identifying varying underlying mechanisms of their chronic pain.
What are the potential side effects?
Since MBSR involves mindfulness practices like meditation, it's generally considered safe with minimal side effects. Some may experience temporary discomfort or emotional distress when learning new ways to deal with their chronic pain.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I experience chronic pain that is not caused by my cancer.
Select...
I have a chronic pain condition that is not lower back pain.
Select...
I have had pain for at least six months, and it's present most days.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot speak or write in English.
Select...
I do not have severe visual or hearing problems.
Select...
I experience chronic pain due to my cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (pre-treatment), 8 and 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (pre-treatment), 8 and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
PROMIS physical function 6b
Secondary study objectives
Change in Chronic Pain Acceptance Questionnaire (CPAQ)-8
Anxiety
Change in Pain Catastrophizing Scale (PCS)
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: MBSR treatmentExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,854 Previous Clinical Trials
6,433,261 Total Patients Enrolled
Todd Favorite, Ph.D.Principal Investigator - University of Michigan
Regents of the University of Michigan, University of Michigan C.S. Mott Children's Hospital, University of Michigan Hospital, Von Voigtlander Women's Hospital

Media Library

MBSR treatment (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04981925 — N/A
Chronic Pain Syndrome Research Study Groups: MBSR treatment
Chronic Pain Syndrome Clinical Trial 2023: MBSR treatment Highlights & Side Effects. Trial Name: NCT04981925 — N/A
MBSR treatment (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04981925 — N/A
~45 spots leftby Jul 2025